Skip to main content

Inhibition of the protein p38 reduces lung tumour growth

24 Jan 20

Images

Participants

Contact

Image
Press and Communications Officer
Tel.+34 93 40 37255

Several media outlets have reported on a study led Angel Nebreda, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona). In this work, his team has observed that p38 inhibition causes a dramatic reduction in the growth and aggressiveness of lung tumours.

Link to: La Vanguardia

Link to: ABC

Link to :El Confidencial

Link to: El Diario de León

Link to: La Voz de Cádiz

 

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).